Cargando…
The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine
Background: Increased understanding of the molecular causes of disease has begun to fulfill the promise of precision medicine with the development of targeted drugs, particularly for serious diseases with unmet needs. The drug approval regulatory process is a critical component to the continued grow...
Autores principales: | Kantor, Ariel, Haga, Susanne B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828670/ https://www.ncbi.nlm.nih.gov/pubmed/33466644 http://dx.doi.org/10.3390/jpm11010045 |
Ejemplares similares
-
Expedited approval system for regenerative medicine products – Is it unusual?
por: Yano, Kazuo, et al.
Publicado: (2016) -
Use of Expedited Regulatory Programs and Clinical Development Times for FDA-Approved Novel Therapeutics
por: Wong, Alissa K., et al.
Publicado: (2023) -
Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
por: Kesselheim, Aaron S, et al.
Publicado: (2015) -
Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study
por: Hwang, Thomas J, et al.
Publicado: (2020) -
Expedited regulatory product approval in the time of COVID-19
por: Novack, Gary D.
Publicado: (2022)